Medical Research
News Category

Engineered tRNA Therapy Shows Promise for Duchenne Muscular Dystrophy
Tevard Biosciences and collaborators published preclinical research demonstrating that engineered suppressor tRNAs can restore full-length dystrophin ...

Laser Therapy Emerges as Promising Brain Cancer Treatment, Offering Alternative to Open Surgery
Researchers at Washington University School of Medicine have advanced laser interstitial thermal therapy (LITT) as a less invasive brain cancer treatm...

Quantum BioPharma's Lucid-MS Gets FDA Clearance for Phase 2 Trial, Offering New Hope in Multiple Sclerosis Treatment
Quantum BioPharma's FDA clearance to test Lucid-MS, a first-in-class remyelinating agent, in a Phase 2 trial marks a pivotal step toward a treatment t...

Timing of Brain Metastasis Predicts Survival in Colorectal Cancer Patients
A study of 5,617 colorectal cancer patients reveals that the timing of brain metastasis development significantly impacts survival, offering crucial p...

Thymus Protection During Lung Cancer Radiotherapy May Improve Survival
New research from Mass General Brigham suggests that minimizing radiation to the thymus during lung cancer treatment could improve patient outcomes, h...

Oragenics Advances Concussion Trial Amid FDA and NYSE American Compliance Updates
Oragenics provides critical updates on its Phase IIa concussion trial, FDA regulatory pathway, and NYSE American listing status, highlighting progress...

Comprehensive Review Offers New Framework for Surgical Decisions in Necrotizing Enterocolitis
A new review in World Journal of Pediatric Surgery synthesizes operative strategies and emerging tools for necrotizing enterocolitis, emphasizing bowe...

Underappreciated Immune Cells Key to Sustained Cancer Fight, University of Manchester Study Reveals
New research from the University of Manchester identifies a little-known group of immune cells as essential for initiating and sustaining the body's a...

NeOnc's NEO100 Phase 2a Success and Regulatory Progress Signal New Era in Brain Cancer Treatment
NeOnc's NEO100 meets primary endpoint in Phase 2a for recurrent brain cancer, showing promising survival data and setting the stage for FDA alignment,...

VolitionRx Publishes Peer-Reviewed Study on Capture-Seq Technology for Ultra-Pure ctDNA Isolation
VolitionRx's new Capture-Seq technology, detailed in a peer-reviewed paper, achieves >99% pure ctDNA isolation, addressing a key liquid biopsy challen...

Biotech Labz Supply Expands Catalog with 11 Documented Research Peptides
Biotech Labz Supply Inc now offers 11 high-purity research peptides with batch-specific COA documentation, streamlining procurement for qualified labo...

VERAXA Biotech Appoints Dr. Christoph Erkel as CSO to Advance BiTAC® Cancer Therapy Platform
VERAXA Biotech has appointed Dr. Christoph Erkel as Chief Scientific Officer to lead the advancement of its proprietary BiTAC® technology platform and...

Experimental Immunotherapy Shows Promise for Pediatric Brain Cancer
Research in Nature Medicine indicates experimental immunotherapy may offer new hope for children with aggressive brain and spinal cord tumors, where c...

iOrganBio Appoints Stem Cell Authority Lee L. Rubin, Ph.D. to Scientific Advisory Board
iOrganBio strengthens its Scientific Advisory Board with Harvard stem cell expert Lee L. Rubin, Ph.D., to accelerate neurological applications of its ...

Dietary Fat Balance Could Influence Immune System Function, Study Finds
A new study reveals that the ratio of polyunsaturated to monounsaturated fats in the diet can affect immune cell membrane composition and susceptibili...

Quantum BioPharma Hits Key Study Milestone with Promising Early MS Imaging Data
Quantum BioPharma announces halfway patient enrollment in a pilot imaging study for multiple sclerosis, with early data showing a meaningful signal in...

Gut microbiome emerges as key player in biliary atresia — could targeting bacteria improve outcomes for infants?
A review in the World Journal of Pediatric Surgery reveals that gut microbiome imbalances are linked to worse outcomes in biliary atresia, suggesting ...

Regentis Biomaterials Receives Japan Patent Allowance for GelrinC Manufacturing Technology
Regentis Biomaterials announced a Japan patent allowance for its GelrinC manufacturing process, strengthening its IP portfolio and positioning in the ...

Study Links Gut Microbial Metabolites to Enhanced Cancer Immunotherapy Sensitivity
A recent study has identified metabolites from gut bacteria that improve responses to cancer immunotherapy, offering insights into patient variability...

NanoViricides Receives Ethics Approval for Phase II Ebola Trial in DRC
NanoViricides announced ethics committee approval in the DRC for a Phase II trial of NV-387 oral gummies against Bundibugyo ebolavirus, positioning it...

Thyroid Hormone Shows Promise in Preventing Pediatric Brain Tumor Recurrence
A research team found that triiodothyronine (T3), a widely prescribed thyroid hormone, combined with standard chemotherapy could prevent recurrence of...

Gum Disease Bacteria Linked to Heart Valve Hardening, Study Suggests
New research presented at the American Heart Association's Basic Cardiovascular Sciences Scientific Sessions 2026 indicates that bacteria from gum dis...

Understanding Treatment Resistance in Cancer: Key Mechanisms and Emerging Solutions
This article explores why treatment resistance occurs in many cancers, highlighting key mechanisms and the work of companies like Calidi Biotherapeuti...

Study Finds Shared Risk Factors for Breast Cancer and Atrial Fibrillation in Older Women
A new global analysis reveals that alcohol use and smoking are linked to higher rates of both breast cancer and atrial fibrillation/flutter in women a...

Bradley A. Maron, M.D., FAHA, Named New Editor-in-Chief of Circulation, Promises Innovation and Transparency
The American Heart Association appoints pulmonary hypertension expert Bradley A. Maron as editor-in-chief of Circulation, signaling a new era of enhan...

New Clinical Pathway Aims to Accelerate Biliary Atresia Diagnosis in Infants
A streamlined diagnostic pathway combining bilirubin testing and feeding ultrasound could enable earlier detection of biliary atresia, improving outco...

Neutrophil extracellular traps identified as key drivers of reperfusion injury across organs
A new review synthesizes evidence that neutrophil extracellular traps (NETs) play a central role in ischemia-reperfusion injury, offering potential bi...

Ace Therapeutics Launches Comprehensive Preclinical Pain Research Services with Full-Spectrum Pain Models
Ace Therapeutics announces end-to-end preclinical analgesic drug development services featuring validated in vivo and in vitro pain models, target-bas...

Amerigo Scientific Launches High-Quality iPSC-Derived Cells to Advance Biomedical Research and Cell Therapy
Amerigo Scientific released high-purity iPSC-derived cells and engineered reporter lines to support disease modeling, drug screening, and cell therapy...

American Heart Association Funds Two Cardiac Arrest Research Teams
The American Heart Association awards $3.4 million in grants to two research teams in New York and Oregon to study prediction, detection, and treatmen...

Immune Biomarkers May Predict Bladder Cancer Therapy Response
Northwestern Medicine researchers have identified immune system markers that could predict which patients respond to BCG bladder cancer therapy, poten...

Study Links TBI to Higher Mortality Risk Due to Brain Cancer
A Mass General Brigham study found that traumatic brain injury increases brain cancer mortality risk, urging long-term monitoring and new treatment ap...

American Heart Association Launches First-Ever Heart Transplant Research Network
The American Heart Association is launching a multi-institutional research network to transform heart transplant care through unified data infrastruct...

Graphene Quantum Dots Show Promise in Targeting Parkinson's-Related Protein Clumping
A multinational research team has found that graphene quantum dots can prevent the aggregation of α-synuclein protein, a hallmark of Parkinson's disea...

Vitamin D Supplementation Enhances Chemotherapy Outcomes in Breast Cancer Patients, Brazilian Clinical Trial Finds
A clinical trial in Brazil demonstrates that daily vitamin D supplementation improves the efficacy of standard chemotherapy in women with breast cance...

Lexaria Extends Material Transfer Agreement with Pharmaceutical Company for GLP-1 Drug Delivery Technology
Lexaria Bioscience Corp. has extended its Material Transfer Agreement with a pharmaceutical company through December 2026 to evaluate its DehydraTECH ...

American Heart Association Mourns the Loss of Dr. Eugene Braunwald, Father of Modern Cardiology
The American Heart Association honors the legacy of Dr. Eugene Braunwald, whose seven decades of work reshaped cardiovascular medicine and who mentore...

$15 Million Research Initiative Targets Early Detection and Prevention of Heart Valve Disease
The American Heart Association funds a $15 million research network across three institutions to study early detection and prevention of valvular hear...

Sigyn Therapeutics Highlights Scientific American Article on Blood-Brain Barrier Leakiness, Supporting CardioDialysis Potential for Neuroinflammatory Diseases
Sigyn Therapeutics notes a Scientific American article covering Trinity College Dublin research showing persistent blood-brain barrier disruption afte...

US~Observer Investigates Alleged Spoofing Involving Quantum BioPharma
An investigative report examines claims of spoofing and market manipulation tied to CIBC's compliance officer and a $700M lawsuit that may have depres...

Combination of Immunotherapy and Laser Heat Therapy Shows Promise for Deadly Brain Tumors
Researchers at Keck Medicine of USC found that combining immunotherapy with laser heat therapy significantly extends survival for patients with deadly...

New Neuroprotective Drug Loberamisal Shows Promise in Improving Stroke Recovery in Phase III Trial
A Phase III clinical trial found that stroke patients treated with loberamisal within 48 hours had significantly better functional outcomes at 90 days...

Adding Clot-Busting Medication After Clot Removal Improves Stroke Recovery, Study Finds
The CHOICE2 trial found that infusing alteplase directly into the brain artery after successful thrombectomy significantly increases the likelihood of...

American Stroke Association Honors 11 Leading Scientists for Stroke and Brain Health Research at International Stroke Conference 2026
The American Stroke Association will recognize 11 scientists at the International Stroke Conference 2026 for their exceptional contributions to stroke...

New Risk Assessment Tool May Help Predict Dementia After a Stroke
A new risk prediction tool accurately identifies stroke survivors at highest risk for developing dementia within a decade, enabling better clinical tr...

Dual Antiplatelet Therapy and Stronger Drugs Linked to Higher Death Risk After Brain Bleed
A new analysis of over 426,000 patients found that those taking multiple antiplatelet medications or stronger agents before an intracranial hemorrhage...

